The DOI matches its Crossref record; 61 of the 63 references it cites were found in a registry or an index.
NMIIA promotes tumor growth and metastasis by activating the Wnt/β-catenin signaling pathway and EMT in pancreatic cancer
Abstract
Non-muscle myosin IIA (NMIIA) protein plays an important role in cell cytokinesis and cell migration. The role and underlying regulatory mechanisms of NMIIA in pancreatic cancer (PC) remain elusive. We found that NMIIA is highly expressed in PC tissues and contributes to PC poor progression by using open microarray datasets from the Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA), and PC tissue arrays. NMIIA regulates β-catenin mediated EMT to promote the proliferation, migration, invasion, and sphere formation of PC cells in vitro and in vivo. NMIIA controls the β-catenin transcriptional activity by interacting with β-catenin. Moreover, MEK/ERK signaling is critical in MLC2 (Ser19) phosphorylation, which can mediate NMIIA activity and regulate Wnt/β-catenin signaling. These findings highlight the significance of NMIIA in tumor regression and implicate NMIIA as a promising candidate for PC treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among the key regulators of PDAC metastasis is the Wnt/β‐catenin pathway.”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [42]
In the citing paper
“Upon activation, this pathway leads to the translocation of β‐catenin into the nucleus where it facilitates the transcription of genes that induce EMT, invasion and migration to distant sites [41, 42]”
From Pyrvinium Pamoate Alone and With Gemcitabine Exhibits Anti‐Pancreatic Cancer Activity in 2D and 3D Cell Culture Models (2024) · cites this paper as [42]
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature reviews. Cancer · doi:10.1038/nrc822 · Cited by 6,767
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Ryan, D. P., Hong, T. S., & Bardeesy, N. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1404198 · Cited by 2,348
Non-muscle myosin II takes centre stage in cell adhesion and migration
Vicente‐Manzanares, M., Ma, X., Adelstein, R. S., & Horwitz, A. R. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2786 · Cited by 2,137
Three-dimensional structure of myosin subfragment-1: a molecular motor
Rayment, I., Rypniewski, W. R., Schmidt‐Bäse, K., Smith, R., Tomchick, D. R., Benning, M. M., Winkelmann, D. A., Wesenberg, G. E., & Holden, H. M. (1993) · Science · doi:10.1126/science.8316857 · Cited by 2,054
Mammalian Rho GTPases: new insights into their functions from in vivo studies
Heasman, S. J., & Ridley, A. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2476 · Cited by 1,871
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway
Coso, O. A., Chiariello, M., Yu, J., Teramoto, H., Crespo, P., Xu, N., Miki, T., & Gutkind, J. S. (1995) · Cell · doi:10.1016/s0092-8674(05)80018-2 · Cited by 1,629
Flagged first, then by citations
2 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–114 of 114
Li, Z., Yang, H.-Y., Zhang, X.-L., Zhang, X., Huang, Y.-Z., Dai, X.-Y., Shi, L., Zhou, G.-R., Wei, J.-F., & Ding, Q. (2022) · Figshare · doi:10.6084/m9.figshare.19728226
Li, Z., Yang, H.-Y., Zhang, X.-L., Zhang, X., Huang, Y.-Z., Dai, X.-Y., Shi, L., Zhou, G.-R., Wei, J.-F., & Ding, Q. (2022) · Figshare · doi:10.6084/m9.figshare.19728229
Li, Z., Yang, H.-Y., Zhang, X.-L., Zhang, X., Huang, Y.-Z., Dai, X.-Y., Shi, L., Zhou, G.-R., Wei, J.-F., & Ding, Q. (2022) · Figshare · doi:10.6084/m9.figshare.19728232
Chen, X., Zhang, Y., Zhang, P., Wei, M., Tian, T., Guan, Y., Han, C., Wei, W., & Ma, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639322
Li, Z., Yang, H.-Y., Zhang, X.-L., Zhang, X., Huang, Y.-Z., Dai, X.-Y., Shi, L., Zhou, G.-R., Wei, J.-F., & Ding, Q. (2022) · Figshare · doi:10.6084/m9.figshare.19728223
Chen, X., Zhang, Y., Zhang, P., Wei, M., Tian, T., Guan, Y., Han, C., Wei, W., & Ma, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26639325
Meng, L., Zhang, Y., Wu, P., Li, D., Lu, Y., Shen, P., Yang, T., Shi, G., Chen, Q., Yuan, H., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19959679
Self-citationCao, M., Wang, Y., Xiao, Y., Zheng, D., Zhi, C., Xia, X., & Yuan, X. (2021) · Figshare · doi:10.6084/m9.figshare.14570654
Meng, L., Zhang, Y., Wu, P., Li, D., Lu, Y., Shen, P., Yang, T., Shi, G., Chen, Q., Yuan, H., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19959682
Self-citationMolecular Pathways and Drugs Involved in the Treatment of Pancreatic Cancer
Yadav, B., Maltonia, D., Singh, A., Kollur, S. P., & Singh, P. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-1469-3.ch001
Therapeutic Potential of Ion Carrier Antibiotics in Ovarian Cancer: Mechanisms and Prospects
Feng, L., Wen, W., & Shujuan, Y. (2026) · Cancer Management and Research · doi:10.2147/cmar.s566921
Characterization of Social and Repetitive Behaviors of Mllt11/Af1q/TcF7c Conditional Knockout Mice
Witt, E. A., Stanton‐Turcotte, D., Garay, P., Ge, J., & Iulianella, A. (2026) · European Journal of Neuroscience · doi:10.1111/ejn.70474
Sun, M., Gao, Z., Ye, P., Ding, Y., Wang, J., Li, T. S., Wang, X., Feng, Y., 任丽华, Zhu, Y., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08554-8
Kang, X., Wei, Y., Cao, F., Zhang, H., Zhou, Y., Zhang, Y., Zhao, H., Roy, M., Bi, X., Ma, Z., et al. (2026) · Genes & Diseases · doi:10.1016/j.gendis.2026.102521
Metadata
- Authors
- Zhou, P., Li, Y., Li, B., Zhang, M., Liu, Y., Yao, Y., & Li, D.
- Affiliations
- Shanghai Jiao Tong University (CN)
- Second Military Medical University (CN)
- Nanjing Medical University (CN)
- Corresponding author
- Liu, Yuanhua
- Li, Dong
- Venue
- Oncogene
- Published
- 2019-04-09
- Volume
- 38
- Issue
- 27
- Pages
- 5500-5515
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2939437655
- Cited by
- 108
- References
- 63
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 13 · 2023: 14 · 2022: 34 · 2021: 19 · 2020: 16 · 2019: 4
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Innovation Program for Ph.D. students in Shanghai Jiaotong University School of Medicine
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- non-muscle myosin IIA, pancreatic cancer, Wnt/β-catenin signaling, epithelial-mesenchymal transition, tumor growth, metastasis, MEK/ERK signaling, myosin light chain 2 phosphorylation, cell proliferation, cell migration and invasion, tumor sphere formation
- MeSH terms
- Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Pancreatic Neoplasms, Myosin Heavy Chains, Cell Proliferation, beta Catenin, Epithelial-Mesenchymal Transition, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
